- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03185507
The Effect of Cryotherapy on Cerebral Hemodynamics Within Healthy Subjects
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The prevalence of concussion has been estimated to be between 4,380 and 10,403 concussions per day in the United States annually with over an estimated 3 million visits to emergency departments each year.1 Symptoms following a concussion last up to 10 days for 90% of cases2; however, the reduction of symptoms in this time frame does not indicate full neurometabolic recovery.
Following concussion, a neurometabolic cascade of events immediately occurs following initial impact with return to normative values around 30 days post-injury. In an attempt to maintain homeostasis in the brain following impact, glucose and oxygen demand increases temporarily and are coupled with periods of increased hyperperfusion and decreased cerebral blood flow (CBF). Although the neurometabolic timeline immediately following impact is only generally understood, there is consensus upon acute increases in CBF and metabolic activity followed by decreased CBF until return to normative values.
Cryotherapy has been studied extensively for its' effects throughout the musculoskeletal system. Cryotherapy in the musculoskeletal system has been shown to decrease tissue temperature and blood flow, as well as decrease oxygen and energy demands.12-19 Cryotherapy has also been applied in cases of moderate or severe traumatic brain injury and has demonstrated to decrease intracranial metabolic processes and oxygenation consumption. Although the potential benefits of cryotherapy have been established in cases of moderate to severe traumatic brain injury (TBI), there is no current research examining cryotherapy in the treatment of concussion.
A convenience sample of 34 healthy, recreationally active individuals between the ages of 18-25 years will be recruited for participation in this study. The independent variable in this study will be group (cryotherapy, control). The primary outcome measures of interest are cognitive functioning measured using the Stroop Test and cerebral blood hemodynamics and hemoglobin saturation measured using near infrared spectroscopy. The pain visual analog scale (VAS) will be used to quantify tolerance to the intervention.
The following study will address the following objectives and related hypotheses:
Objective 1: To determine if the application of cryotherapy influences intracranial hemodynamics within healthy recreationally active young adults.
Hypothesis 1: Cryotherapy will cause a decrease in intracranial hemodynamics; specifically, the CO2 saturation and deoxygenated hemoglobin causing a decrease in intracranial metabolic activity.
Objective 2: To determine if the application of cryotherapy decreases cerebral blood flow within healthy recreationally active individuals.
Hypothesis 2: The application of cryotherapy will not cause a change in cerebral blood flow due to the highly regulated central nervous system.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 1
Kontakter og lokationer
Studiesteder
-
-
Virginia
-
Charlottesville, Virginia, Forenede Stater, 22904
- University of Virginia Memorial Gymnasium
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Between 18 and 25 years of age
- Recreationally active (exercise at least 30 minutes, 3 times weekly)
Exclusion Criteria:
- Contraindications for cryotherapy (eg. Raynaud's phenomenon, cold urticaria)
- Any documented learning difficulty or disability
- Any known neurological or psychiatric disorder
- History of migraines
- History of a concussion or traumatic brain injury in past 6 months
- Currently taking psychotropic medications
- Any known metabolism diseases
- Any known hematological diseases
- Any recreational drug use in past month
- Any known cardiopulmonary impairments or pathologies
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Cryotherapy
Participants received superficial cryotherapy using the Cryohelmet(TM)
|
Cryotherapy was administered using the Catalyst CryoHelmet™ (All-Star Sporting Goods®, Shirley, Massachusetts, USA).
The CyroHelmet is a flexible helmet equipped with gel ice packs meant to cool the head and neck.
|
|
Ingen indgriben: Control
Participants sat quietly for 20 minutes
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Oxygenated blood
Tidsramme: Oxygenated blood was collected throughout the data collection period (45 minutes)
|
Oxygenated blood based on functional near-infrared spectroscopy (fNIRS) data output
|
Oxygenated blood was collected throughout the data collection period (45 minutes)
|
|
Deoxygenated blood
Tidsramme: Dexoygenated blood was collected throughout the data collection period (45 minutes)
|
Deoxygenated blood based on functional near-infrared spectroscopy (fNIRS)
|
Dexoygenated blood was collected throughout the data collection period (45 minutes)
|
|
Stroop Task reaction time
Tidsramme: Stroop Task reaction time was collected prior to and following the intervention. Each test took approximately 5 minutes to complete.
|
Reaction time measured in milliseconds while completing the Stroop Task
|
Stroop Task reaction time was collected prior to and following the intervention. Each test took approximately 5 minutes to complete.
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 19706
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Iltmangel
-
Damascus UniversityAfsluttetSkelet Maxillary Transversal DeficiencySyrien Arabiske Republik
-
Cairo UniversityIkke rekrutterer endnuSocket Preservation, Alveolar Ridge Deficiency, Alveolar Ridge Preservation
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRekrutteringACL - Anterior Cruciate Ligament DeficiencyFrankrig
-
University Hospital, CaenInstitut National de la Santé Et de la Recherche Médicale, FranceUkendtACL-rivning | ACL - Anterior Cruciate Ligament DeficiencyFrankrig
-
GCS Ramsay Santé pour l'Enseignement et la RechercheRekrutteringACL - Anterior Cruciate Ligament DeficiencyFrankrig
-
OrthoCarolina Research Institute, Inc.AfsluttetACL skade | ACL-rivning | ACL - Anterior Cruciate Ligament DeficiencyForenede Stater
-
Chang Gung Memorial HospitalUkendtACL skade | ACL - Forreste korsbåndsruptur | ACL - Anterior Cruciate Ligament DeficiencyTaiwan
-
Baxter Healthcare CorporationAfsluttetEssential Fatty Acid Deficiency (EFAD)Forenede Stater
-
Steadman Philippon Research InstituteÖssur Iceland ehfTrukket tilbageACL | ACL skade | ACL - Forreste korsbåndsruptur | ACL - Anterior Cruciate Ligament DeficiencyForenede Stater
-
The Hospital for Sick ChildrenBristol-Myers SquibbAfsluttetRefraktære eller tilbagevendende hypermuterede maligniteter | Biallelic Mismatch Repair Deficiency (bMMRD) Positive patienterForenede Stater, Frankrig, Canada, Australien, Israel